306 related articles for article (PubMed ID: 7638778)
1. [The long-term parenteral use of cyclophosphane in treating patients with systemic lupus erythematosus and central nervous system involvement].
Ivanova MM; Bliziuk OI; Travkina IV
Ter Arkh; 1995; 67(5):45-7. PubMed ID: 7638778
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system manifestations in juvenile systemic lupus erythematosus: a problem of management.
Davies UM; Ansell BM
J Rheumatol; 1988 Nov; 15(11):1720-1. PubMed ID: 3236306
[TBL] [Abstract][Full Text] [Related]
3. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
[TBL] [Abstract][Full Text] [Related]
4. [Combined use of impact doses of 6-methylprednisolone and cyclophosphamide in patients with systemic lupus erythematosus].
Solov'ev SK; Ivanova MM; Nasonov EL; Anan'eva LP; Sazhina EG
Ter Arkh; 1985; 57(8):7-12. PubMed ID: 2933841
[TBL] [Abstract][Full Text] [Related]
5. [A case of mixed connective tissue disease with lupus-like manifestations of the central nervous system, successfully treated with cyclophosphamide combined with prednisolone].
Kuroki M; Okayama A; Kuwata G; Okamoto M; Tanaka G; Iga M; Kai Y; Matsuyama M; Murai K; Tsubouchi H
Ryumachi; 2000 Jun; 40(3):627-32. PubMed ID: 10920688
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of systemic lupus erythematosis with high doses of cyclophosphamide].
Baranowska-Daca E
Wiad Lek; 1993 Nov; 46(21-22):868-71. PubMed ID: 7817583
[TBL] [Abstract][Full Text] [Related]
7. Livedoid vasculitis and central nervous system involvement in systemic lupus erythematosus.
Yasue T
Arch Dermatol; 1986 Jan; 122(1):66-70. PubMed ID: 3942409
[TBL] [Abstract][Full Text] [Related]
8. [Methylprednisolone pulse therapy for SLE patients with CNS disorder].
Ichikawa Y; Hashimoto H; Kashiwazaki S; Kondo H; Akizuki M; Tokanou Y
Ryumachi; 1994 Aug; 34(4):733-43. PubMed ID: 7974024
[TBL] [Abstract][Full Text] [Related]
9. [Methylprednisolone shock dose therapy of systemic lupus erythematosus with central nervous system involvement].
Alekberova ZS; Folomeeva OM; Savinov VA; Berezova NIu
Vopr Revm; 1981; (4):60-1. PubMed ID: 7331277
[No Abstract] [Full Text] [Related]
10. [Synchronizing therapy with plasmapheresis and cyclophosphamide in rapidly progressing systemic lupus erythematosis with kidney involvement].
Demin AA; Sentiakova TN; Smirnov VV; Demina LM; Mamin IV
Ter Arkh; 1996; 68(5):27-30. PubMed ID: 9082593
[TBL] [Abstract][Full Text] [Related]
11. [Use of high doses of glucocorticoids in patients with rheumatic diseases].
Dormidontov EN; Korshunov NI; Baranova EIa; Zheltkevich SN; Razumova EB
Ter Arkh; 1985; 57(8):12-6. PubMed ID: 4071425
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations].
De Bandt M; Goycochea MV; Meyer O; Delahousse M; Palazzo E; M'Bappé P; Kahn MF
Ann Med Interne (Paris); 1994; 145(2):75-87. PubMed ID: 8024184
[TBL] [Abstract][Full Text] [Related]
13. [Effects of therapies on childhood systemic lupus erythematosus].
Kurosawa R; Umezawa R; Kobayashi Y; Nakajima S; Miyamae T; Ito S; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S
Ryumachi; 2003 Oct; 43(4):632-7. PubMed ID: 14598654
[TBL] [Abstract][Full Text] [Related]
14. The one-and-a-half syndrome in systemic lupus erythematosus.
Yiğit A; Bingöl A; Mutluer N; Taşçilar N
J Neuroophthalmol; 1996 Dec; 16(4):274-6. PubMed ID: 8956164
[TBL] [Abstract][Full Text] [Related]
15. [Effect and limitation of intravenous methylprednisolone pulse therapy in the long-term follow-up of childhood systemic lupus erythematosus].
Yokota S; Shimizu H; Aihara Y; Mitsuda T; Ibe M; Kuriyama T; Mori T; Kosuge K
Ryumachi; 1992 Jun; 32(3):215-22. PubMed ID: 1523523
[TBL] [Abstract][Full Text] [Related]
16. [A case of systemic lupus erythematosus with various central and peripheral neurological disorders presenting with motor paralytic bladder as a major manifestation].
Horiki T; Moriuchi J; Kouzuma R; Haida M; Watanabe S; Katsuoka Y; Ichikawa Y
Ryumachi; 1995 Oct; 35(5):821-6. PubMed ID: 8594661
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone cyclophosphamide pulse therapy in systemic lupus erythematosus: a case report.
Gupta R; Gupta S; Khera V
J Dermatolog Treat; 2009; 20(1):55-8. PubMed ID: 18618362
[TBL] [Abstract][Full Text] [Related]
18. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.
Yee CS; Gordon C; Dostal C; Petera P; Dadoniene J; Griffiths B; Rozman B; Isenberg DA; Sturfelt G; Nived O; Turney JH; Venalis A; Adu D; Smolen JS; Emery P
Ann Rheum Dis; 2004 May; 63(5):525-9. PubMed ID: 15082482
[TBL] [Abstract][Full Text] [Related]
19. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
Petri M; Jones RJ; Brodsky RA
Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
[TBL] [Abstract][Full Text] [Related]
20. [A recovered case of SLE with central nervous system involvement who relapsed presenting new symptoms associated with development of serum anti-Sm antibody].
Hiura K; Abe T; Hatanaka Y; Ikeda Y; Akaike J; Hosokawa A; Itoh Y; Takagi H; Sakai H; Suwa T; Yonezawa K; Tosaka M; Chiba S; Imai K
Ryumachi; 1998 Feb; 38(1):39-44. PubMed ID: 9564777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
